Digital Diabetes Management Market (By Product: Devices, Application, Data Management Software & Platforms, Services; By Device Type: Handheld Devices, Wearable Devices; By Patient Type: Type 1, Type 2; By App: Digital Diabetes Management Apps, Weight & Diet Management Apps; By End-Use: Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030

The global digital diabetes management market size was accounted at US$ 19.02 billion in 2021 and it is projected to be worth around US$ 90 billion by 2030, growing at a registered CAGR of 18.85% from 2022 to 2030.

Digital Diabetes Management Market Size 2021 to 2030

Growth Factors

The increasing number of diabetic patients across the world will benefit due to the increasing use of digital diabetes management products and services. As per the International Diabetes Federation (IDF), about 463 million populations across the world were living with diabetes, in the year 2019. There is a demand for continuous monitoring of blood glucose among the diabetic patients which will highly affect the global market growth during the forecast period.

The use of smart insulin pens is in great demand due to the various benefits associated with the use of these pens. It helps in recording the amount of each insulin dose and transmits the collected data of the insulin dose using the connected Bluetooth devices. This is a major benefit offered by the advanced digital diabetes management solutions. The manufacturers of smart insulin pens are incorporating new features to this product which are making it more user-friendly for the diabetes patients. Patients with type one diabetes or dependent on insulin and they need consistent monitoring of blood glucose levels beaded there has been an increase in the demand for digital diabetes solutions among this patient base.

The prevalence of the type one diabetes across the globe is also creating a great demand for this product. The preference of traditional diabetes management techniques, huge cost associated with the devices and dearth of reimbursement facilities in the less developed nations are the major factors that are predicted to hamper the progress of the digital diabetes management market during the forecast period. The rise in concerns of the security of data and less penetration in developing nations is expected to hamper the digital diabetes management market in the future.

Increasing use of wearable technologies in the diabetes preventive care is a key factor in the adoption of digital diabetes management devices by many diabetic patients. Liking for smart devices among the diabetic patients is proving to be  helpful in real time monitoring and decision making which is dependent on the results and this will continue to help in the growth of the market during the forecast period. The product preference is increasing due to various qualities like it being extremely user-friendly and convenience to use and it does not affect individuals’ daily activities. Due to the introduction of diabetes awareness campaigns and other initiatives by various governments is leading to the market growth. Media campaigns and activities by these companies for diabetes care and prevention are helpful in increasing the awareness regarding the presence of various technologies in this business.

The major market players operating in the digital diabetes management are determined and focusing on the innovations in these products and they are offering technologically advanced products for the diabetic patients. As digital diabetes management products are turning to be more integral part in the disease management for good outcomes, it presents many opportunities for these innovative devices in the market place. The growing adoption for digital technologies regarding disease management among diabetes patients helped the market to grow as there was a high risk of getting infected with COVID.

Pertaining to the diabetic patients being highly vulnerable to COVID-19 infections, the system recommended constant tracking of blood sugar level in order to reduce the unseen complications. The pandemic created a global scenario which made it important to assess the feasibility and effectiveness of various digital devices across the heathcare units to reserve hospital staff for the pandemic and proper management of the patients with other diseases. In the future the AI based digital diabetes management products will help in providing customized solution for hypoglycemia control to the consumers. The product was developed and designed to provide tailored understanding to patients about the response of glucose level based on their food consumption, insulin dose and daily timetable. Thus, usage, and availability of such novel, advanced and booming technologies in the field of digital diabetes management will improve the market growth during the forecast period.

Report Scope of the Digital Diabetes Management Market

Report Coverage Details
Market Size by 2030 USD 90 Billion
Growth Rate from 2022 to 2030

CAGR of 18.85%

Largest Market North America
Fastest Growing Region Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Device Type, Patient Type, App, End-Use, Geography
Companies Mentioned Bayer AG, Medtronic, Roche Diagnostics, Dexcom Inc. LifeScan Inc., AgaMatrix, One Drop, Abbott Laboratories, Ascensia Diabetes Care, ARKRAY Inc, ACON Laboratories, Insulet Corporation


Product Insights

On the basis of the product type, the services segment in the digital diabetes management market is further classified into software and applications. The devices market is segmented into smart insulin pumps smart insulin pens, smart continuous glucose monitors and smart blood glucose meters. The continuous glucose monitors devices had the largest revenue share 48% in 2021 and it is anticipated to have growth of 20% CAGR during the timeline. This segment is expected to grow during the forecast. Due to the factors like continuous technological advancements, increase in the number of products launched, increase in the integration of remote monitoring technologies in the devices increasing the availability of these devices and growing awareness amongst the population. Abott introduced a freestyle libre system In the Indian market by expanding its offerings to this market. The use of this device will help in monitoring the real time blood glucose readings of a patient. It also helps in providing complete overview of the individual glucose levels. Due to any increased awareness and increasing availability of this advanced continuous glucose monitoring devices the usage of this novel technology will lead to the growth of this segment during the forecasted period.

Also, smart insulin pen segment is gaining a good growth and is expected to grow at the highest CAGR of 21.9% in the future. Increase in the product launches in the market of digital healthcare sector and introduction of artificial intelligence are the key factors that help to the fullest for the segmental growth the smart insulin pen across the globe.

The weight and the diet management applications segments have a good share in the world market due to increase in the awareness of chronic diseases such as diabetes and other complications related to this disease. These apps use advanced digital data analytics technology that helps the healthcare professionals to give satisfactory service to the consumers with the best possible solutions. The improved health outcomes, less amount of error rates and reducing healthcare costs are the major factors that result in the growth of the apps segment worldwide. Insulin delivery is an extremely important part of diabetes management.

Patient Type Insights

On the basis of the patient type, the type 2 digital diabetes management segment dominated the market and garnered market share of about 90% in terms of revenue in 2021. Due to the prevailing number of patients suffering from type 2 diabetes are creating a great demand for these products. Out of the total number of diagnosed cases of diabetes in the US there are 90% patients which have type 2 diabetes.

Digital Diabetes Management Market Share, By Patient Type, 2021 (%)

Type 2 diabetes increases the risk of adult blindness it increases the risk of kidney failure and it may lead to lower limb amputation. Owing to all of these reasons the usage of digital diabetes management is in this segment is expected to grow during the forecast period. Due to an increase in the consumption of unhealthy and junk diet combined with the lack of physical activity caused due to a sudden tree lifestyle is increasing the cases of type 2 diabetes in this region. The cases of type 2 diabetes are increasing across the globe. The market for monitoring devices is driven by the higher prevalence rate of these diseases amongst the patients. All of these factors will boost the demand for this product in the future.

End User Insights

On the basis of the end user, the digital diabetes management market is segmented into diagnostic centers clinics hospitals and home settings. The home settings segment had an important position in the consumption of these devices. The revenue generated from the home settings segment was how your add compared to any other segment. This segment is expected to see a growth of about 21.7% CAGR during the timeline. The devices offered to the market have a user friendly interface which is integrated with advanced digital devices. Increasing awareness regarding the diabetes care amongst the patients is creating a need for adoption of these devices. As these devices are helpful in sharing important data with the help of digital platforms to the professional is expected to give a boost to this market. Access to professionals from the home settings across the globe is expected to dry the market in the future. During the pandemic the home settings segment had a great demand of digital diabetes management products as it favored the conditions. The use of mobile applications and other connected devices at home during the pandemic provided a great boost to this market.

Digital diabetes management market from the hospitals segment had a 37.5% revenue share in the year 2021 and is expected to witness good CAGR in the forecast timeframe. Increased use of digital technologies in remote patient monitoring with increase in the patients visits by professionals will drive the demand for this product adoption.

Regional Insights

The North American digital diabetes management market had the largest share in terms of revenue till the recent years. The growth in this region is due to many factors like the focus on continuous technological advancements, upcoming product launches with advanced features and the presence of major market players in the North American region. Due to an increasing population of the diabetic patients in this region is creating growth opportunities for the major market players. The prevalence of diabetes and the presence of favorable reimbursement policies in the North American region is stimulating the growth of the market beard the system launched by  Abott in September 2020 Has a cover under the Medicare which helps in providing better management of diabetes. Owing to all of these factors there'll be a significant increase in the demand for digital diabetes management products in the North American region during the forecasted period.

Digital Diabetes Management Market Share, By Region, 2021 (%)

Europe digital diabetes management market had about 28% business share in 2021 and it is expected to grow at a good rate during the forecast period. Additionally, the presence of large competitors in the Europian region, new product launches, and the introduction of good reimbursement policies are expected to improve the regional market.

Asia Pacific expected to register the fastest growth during future period. Numerous factors, like rise in the number of people suffering with diabetes, rising healthcare expenses and increasing number of market competitors in this region are predicted to support the growth of this market. Disposable income which has increased overtime in this region and rising health awareness about diabetes and the other associated health disorders are further predicted to encourage the growth of this regional segment.

Key market players in the digital diabetes management market

  • Bayer AG
  • Medtronic
  • Roche Diagnostics
  • Dexcom Inc. LifeScan Inc.
  • AgaMatrix
  • One Drop
  • Abbott Laboratories
  • Ascensia Diabetes Care
  • ARKRAY Inc
  • ACON Laboratories
  • Insulet Corporation
  • B. Braun Melsungen AG
  • Tandem Diabetes Care
  • Dottli
  • Ypsomed Holding AG
  • Becton Dickinson and Company
  • Glooko Inc.
  • DarioHealth
  • Care innovations

Recent Developments

  • Dexcom Inc., announced the launch of G6 CGM system in September 2020, in Turkey. The product launch has expanded its business in the international market.
  • U.S. FDA approval which was granted to Abbott Laboratories in June 2020, for its CGM device, FreeStyle Libre 2, has supported the company in widening its product sector, and thus encouraging the company’s footprint in the universal market.

Segments covered in the report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Product

  • Devices
    • Smart Glucose Meters
    • Continuous Glucose Monitoring (CGM) Systems
    • Smart Insulin Pens
    • Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
  • Application
    • Diabetes & Blood Glucose Tracking Apps
    • Obesity & Diet Management Apps
  • Data Management Software & Platforms
  • Services
    • Apps
    • Software

By Device Type

  • Handheld Devices
  • Wearable Devices

By Patient Type

  • Type 1
  • Type 2

By App

  • Digital Diabetes Management Apps
  • Weight & Diet Management Apps

By End-Use

  • Hospitals
  • Home Settings
  • Diagnostic Centers & Clinics

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of digital diabetes management market?
The global digital diabetes management market size was reached at US$ 19.02 billion in 2021 and it is anticipated to rake around US$ 90 billion by 2030.
The global digital diabetes management market is poised to hit growth at a CAGR of 18.85% from 2022 to 2030.
The major players operating in the digital diabetes management market are Bayer AG, Medtronic, Roche Diagnostics, Dexcom Inc. LifeScan Inc., AgaMatrix, One Drop, Abbott Laboratories, Ascensia Diabetes Care, ARKRAY Inc, ACON Laboratories, and Insulet Corporation.
The major industry leaders operating in the digital diabetes management are focusing on providing innovative products and introducing advanced technologies in this market.
North America dominated the digital diabetes management market in 2021 and will remains its dominance over the forecast period.
  • Report Code:1783
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published


   USD 4500
   USD 7000
   USD 9000


No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample